Leatherback Sea Turtle vs

Dermochelys coriacea compared with Staphylococcus capitis

Key Differences

Leatherback Sea Turtle is Vulnerable while is Not Evaluated.

Taxonomic Classification

Rank	Leatherback Sea Turtle
Kingdom	Animalia (Animals)	Bacteria (Bacteria)
Phylum	Chordata (Chordates)	Firmicutes (Firmicutes)
Class	Reptilia (Reptiles)	Bacilli (Bacilli)
Order	Testudines (Turtles & Tortoises)	Staphylococcales
Family	Cheloniidae (Sea Turtles)	Staphylococcaceae
Genus	Chelonia (Green Sea Turtles)	Staphylococcus
Species	Dermochelys coriacea	Staphylococcus capitis

Conservation Status

Leatherback Sea Turtle

VU — Vulnerable

Population: ~35.0K

Trend: Decreasing ↓

NE — Not Evaluated

Physical Characteristics

Attribute	Leatherback Sea Turtle
Diet	Carnivore	—
Average Lifespan	50 years	—
Average Length	2.0 m	—
Average Weight	500.0 kg	—

Habitat & Geographic Range

Leatherback Sea Turtle

Habitat

Found across multiple habitat types including tropical and subtropical moist broadleaf forests, tropical and subtropical dry broadleaf forests, and tropical and subtropical grasslands and savannas, among 5 distinct biome types spanning the Australasia and Indomalayan and Neotropic realms. Populations are also found in montane and highland environments at higher elevations.

Range

Distributed across Costa Rica, Indonesia, Malaysia, and Trinidad and Tobago. Currently classified as Vulnerable on the IUCN Red List, this species faces significant conservation challenges across its range.

Habitat

Native to Asia, inhabiting ecosystems characteristic of the region.

Range

Found in Taiwan.

Leatherback Sea Turtle

The leatherback is the largest living turtle and the fourth-heaviest reptile. Unlike other turtles, it has a soft, leathery shell.

Staphylococcus capitis is a coagulase-negative, Gram-positive coccus commonly found on the human scalp and face, particularly in sebaceous gland-rich areas. It is part of the normal skin microbiome of humans and primates. This commensal bacterium feeds on skin lipids and occasionally causes opportunistic infections in neonates and immunocompromised patients.